Search research articles
Contact Us
Filters
Showing results (371-380 of 381) with videos related to
Page
of 39
Sort By:
Digestive Diseases and Sciences
|
June 21, 2001
Dose-dependent conjugation of sulfobromophthalein and hepatic transit time in bile fistula rats: role of the microtubule-dependent vesicle pathway
S Tazuma, K Horikawa, H Ochi, et al.
Human Genetics
|
September 10, 1999
Association between M/L55-polymorphism of paraoxonase enzyme and oxidative DNA damage in patients with type 2 diabetes mellitus and in control subjects
R Malin, V Rantalaiho, X H Huang, et al.
Journal of Cardiography
|
September 1, 1982
[Quantitative evaluation of regional wall motion abnormality by phase analysis using RI multigated method]
H Minamikawa, Y Ikuno, K Akioka, et al.
Journal of Viral Hepatitis
|
September 15, 2011
IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinoma
T Kawaoka, H Aikata, S Takaki, et al.
Journal of Viral Hepatitis
|
June 20, 2014
Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1
K Kosaka, M Imamura, C N Hayes, et al.
British Journal of Cancer
|
September 5, 2013
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
M Takano, H Ochi, Y Takei, et al.
Transplantation Proceedings
|
April 21, 2015
Two patients treated with simeprevir plus pegylated-interferon and ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation: case report
T Kawaoka, M Imamura, H Kan, et al.
Osteoarthritis and Cartilage
|
October 28, 2017
Angiopoietin-like protein 2 promotes chondrogenic differentiation during bone growth as a cartilage matrix factor
H Tanoue, J Morinaga, T Yoshizawa, et al.
Journal of Clinical Gastroenterology
|
July 2, 1998
A combination therapy with simvastatin and ursodeoxycholic acid is more effective for cholesterol gallstone dissolution than is ursodeoxycholic acid monotherapy
S Tazuma, G Kajiyama, T Mizuno, et al.
ESMO Open
|
November 30, 2021
Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib
M Rimini, M Kudo, T Tada, et al.
Page
of 39
Search research articles
Search
Showing results (371-380 of 381) with videos related to
Sort By:
Page
of 39
Digestive Diseases and Sciences
|
June 21, 2001
Dose-dependent conjugation of sulfobromophthalein and hepatic transit time in bile fistula rats: role of the microtubule-dependent vesicle pathway
S Tazuma, K Horikawa, H Ochi, et al.
Human Genetics
|
September 10, 1999
Association between M/L55-polymorphism of paraoxonase enzyme and oxidative DNA damage in patients with type 2 diabetes mellitus and in control subjects
R Malin, V Rantalaiho, X H Huang, et al.
Journal of Cardiography
|
September 1, 1982
[Quantitative evaluation of regional wall motion abnormality by phase analysis using RI multigated method]
H Minamikawa, Y Ikuno, K Akioka, et al.
Journal of Viral Hepatitis
|
September 15, 2011
IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinoma
T Kawaoka, H Aikata, S Takaki, et al.
Journal of Viral Hepatitis
|
June 20, 2014
Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1
K Kosaka, M Imamura, C N Hayes, et al.
British Journal of Cancer
|
September 5, 2013
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
M Takano, H Ochi, Y Takei, et al.
Transplantation Proceedings
|
April 21, 2015
Two patients treated with simeprevir plus pegylated-interferon and ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation: case report
T Kawaoka, M Imamura, H Kan, et al.
Osteoarthritis and Cartilage
|
October 28, 2017
Angiopoietin-like protein 2 promotes chondrogenic differentiation during bone growth as a cartilage matrix factor
H Tanoue, J Morinaga, T Yoshizawa, et al.
Journal of Clinical Gastroenterology
|
July 2, 1998
A combination therapy with simvastatin and ursodeoxycholic acid is more effective for cholesterol gallstone dissolution than is ursodeoxycholic acid monotherapy
S Tazuma, G Kajiyama, T Mizuno, et al.
ESMO Open
|
November 30, 2021
Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib
M Rimini, M Kudo, T Tada, et al.
Page
of 39